- Home
- NEWT vs AVIR Comparison
NEWT vs AVIR Comparison
Compare NEWT & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEWT
- AVIR
- Stock Information
- Founded
- NEWT 1998
- AVIR 2012
- Country
- NEWT United States
- AVIR United States
- Employees
- NEWT N/A
- AVIR N/A
- Industry
- NEWT Major Banks
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- NEWT Finance
- AVIR Health Care
- Exchange
- NEWT Nasdaq
- AVIR Nasdaq
- Market Cap
- NEWT 342.5M
- AVIR 290.4M
- IPO Year
- NEWT N/A
- AVIR 2020
- Fundamental
- Price
- NEWT $13.53
- AVIR $3.56
- Analyst Decision
- NEWT Hold
- AVIR Hold
- Analyst Count
- NEWT 3
- AVIR 1
- Target Price
- NEWT $12.33
- AVIR $6.88
- AVG Volume (30 Days)
- NEWT 158.0K
- AVIR 152.3K
- Earning Date
- NEWT 11-06-2024
- AVIR 11-06-2024
- Dividend Yield
- NEWT 5.61%
- AVIR N/A
- EPS Growth
- NEWT 18.20
- AVIR N/A
- EPS
- NEWT 1.66
- AVIR N/A
- Revenue
- NEWT $301,043,000.00
- AVIR N/A
- Revenue This Year
- NEWT N/A
- AVIR N/A
- Revenue Next Year
- NEWT $6.30
- AVIR N/A
- P/E Ratio
- NEWT $8.10
- AVIR N/A
- Revenue Growth
- NEWT 54.13
- AVIR N/A
- 52 Week Low
- NEWT $10.07
- AVIR $2.77
- 52 Week High
- NEWT $15.75
- AVIR $4.60
- Technical
- Relative Strength Index (RSI)
- NEWT 65.25
- AVIR 49.38
- Support Level
- NEWT $12.34
- AVIR $3.31
- Resistance Level
- NEWT $13.85
- AVIR $3.86
- Average True Range (ATR)
- NEWT 0.34
- AVIR 0.12
- MACD
- NEWT 0.10
- AVIR 0.03
- Stochastic Oscillator
- NEWT 82.89
- AVIR 46.90
About NEWT NewtekOne Inc.
NewtekOne Inc is a financial holding company engaged in providing financial solutions, It has developed a financial and technology-based business model that enables itself to acquire and process its clients in a very cost-effective manner. This capability is supported in large part by NewTracker, its patented prospect management technology software, that will allow NewtekOne clients to easily interact with NewtekOne subject matter experts in the areas of Banking, Lending, Payments, Technology, Payroll, and Insurance. It offers NewtekOne's clients a single online dashboard to access all of NewtekOne's business and financial solutions. It has four reportable segments Banking, Technology, NSBF, and Payments.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).